Comparative effectiveness of treatment with the first TNF antagonist in monotherapy, the first TNF antagonist plus one conventional synthetic disease-modifying antirheumatic drug, and the first TNF antagonist plus two or more conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis

類似資料

• Leflunomide monotherapy versus combination therapy with conventional synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis: a retrospective study
  著者:: Deng, Daihua, 等
  出版事項: (2020)
• Safety and Efficacy of Baricitinib in Patients Receiving Conventional Synthetic Disease-Modifying Antirheumatic Drugs or Corticosteroids
  著者:: van Vollenhoven, Ronald, 等
  出版事項: (2018)
• Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis
  著者:: Emery, Paul, 等
  出版事項: (2013)
• Effects of Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Response to Periodontal Treatment in Patients with Rheumatoid Arthritis
  著者:: Gyu-Un Jung, 等
  出版事項: (2018-01-01)
• Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs
  著者:: Charles-Schoeman, Christina, 等
  出版事項: (2016)